MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
Insider CIK 1734817 · TRDA 10% owner · ITOS 10% owner · DYN 10% owner · AKTS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 5,000,000 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 6,000,000 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 22,500,000 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-14 | 1,112,777 | $18.00 | $20.03M | 10,260,064 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 1,314,262 | — | $0 | 1,655,971 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 5,914,197 | — | $0 | 7,570,168 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 1,577,119 | — | $0 | 9,147,287 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-05-13 | 2025-05-15 | 630,191 | $8.06 | $5.08M | 2,108,594 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-11 | 2024-12-12 | 21,787 | $20.23 | $440.8K | 4,381,062 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 22,935 | $20.77 | $476.4K | 4,402,849 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 18,135 | $42.03 | $762.2K | 2,738,785 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 7,671 | $46.47 | $356.5K | 2,756,920 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 6,768 | $45.32 | $306.7K | 2,764,591 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 94,745 | $42.05 | $3.98M | 2,790,725 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 19,366 | $43.20 | $836.6K | 2,771,359 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 17,962 | $33.15 | $595.4K | 2,886,964 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 1,494 | $34.11 | $51.0K | 2,885,470 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 60 | $35.04 | $2.1K | 2,904,926 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 508 | $34.08 | $17.3K | 2,904,986 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 8,469 | $32.35 | $274.0K | 2,906,665 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 1,171 | $33.57 | $39.3K | 2,905,494 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 2,419 | $35.44 | $85.7K | 2,915,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 179 | $36.26 | $6.5K | 2,915,134 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 17,569 | $34.68 | $609.3K | 2,917,732 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 29,757 | $33.74 | $1.00M | 2,942,731 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 7,430 | $34.83 | $258.8K | 2,935,301 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 896 | $35.34 | $31.7K | 2,972,488 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 5,457 | $34.61 | $188.9K | 2,973,384 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 6,042 | $33.82 | $204.3K | 2,978,841 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 5,861 | $34.62 | $202.9K | 3,012,959 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 28,076 | $35.19 | $988.0K | 2,984,883 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 10,073 | $34.46 | $347.1K | 3,019,118 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 298 | $35.37 | $10.5K | 3,018,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,129 | $36.03 | $220.8K | 3,029,191 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,545 | $35.49 | $232.3K | 3,035,320 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 13,126 | $37.02 | $485.9K | 3,041,865 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 4,868 | $35.20 | $171.4K | 3,073,334 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 18,343 | $36.05 | $661.3K | 3,054,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 359 | $36.50 | $13.1K | 3,078,202 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 19,645 | $36.21 | $711.3K | 3,078,561 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 11,807 | $37.81 | $446.4K | 3,098,206 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 9,307 | $37.16 | $345.8K | 3,110,013 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-11-17 | 2021-11-24 | 15,671 | — | $0 | 3,119,320 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 3,683,241 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 27,617,675 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 509,024 | — | $0 | 4,325,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 100,000 | $20.00 | $2.00M | 4,425,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 3,816,760 | — | $0 | 3,816,760 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-18 | 2021-10-18 | 6,167 | $27.14 | $167.4K | 3,134,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 2,039 | $28.01 | $57.1K | 3,141,158 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 8,893 | $27.53 | $244.8K | 3,143,197 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-14 | 2021-10-14 | 27,320 | $27.30 | $745.8K | 3,152,090 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-13 | 2021-10-14 | 20,929 | $27.13 | $567.8K | 3,179,410 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-12 | 2021-10-14 | 8,521 | $27.09 | $230.8K | 3,200,339 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 48,812 | $27.24 | $1.33M | 3,208,860 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 2,032 | $27.01 | $54.9K | 3,257,672 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-12 | 1,149 | $27.00 | $31.0K | 3,259,704 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 20,711 | $27.06 | $560.4K | 3,260,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 6,855 | $27.00 | $185.1K | 3,281,564 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-30 | 2021-09-30 | 2,292 | $27.00 | $61.9K | 3,288,419 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-28 | 2021-09-30 | 19,214 | $27.00 | $518.8K | 3,290,711 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-27 | 2021-09-27 | 11,625 | $27.09 | $314.9K | 3,309,925 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-24 | 2021-09-27 | 4,913 | $27.81 | $136.6K | 3,321,550 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 36,213 | $27.96 | $1.01M | 3,327,180 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 717 | $28.38 | $20.3K | 3,326,463 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 14,294 | $27.54 | $393.7K | 3,363,393 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 19,635 | $27.47 | $539.4K | 3,377,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 13,701 | $27.84 | $381.4K | 3,397,322 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 10,602 | $27.03 | $286.6K | 3,411,023 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-17 | 2021-09-20 | 45,698 | $28.82 | $1.32M | 3,421,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 21,253 | $28.47 | $605.1K | 3,467,323 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 23,113 | $27.79 | $642.3K | 3,489,567 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 991 | $28.15 | $27.9K | 3,488,576 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 17,938 | $27.50 | $493.3K | 3,516,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 3,623 | $27.99 | $101.4K | 3,512,680 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-13 | 2021-09-13 | 21,384 | $27.64 | $591.1K | 3,534,241 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,771 | $28.73 | $194.5K | 3,555,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,760 | $27.86 | $188.3K | 3,562,396 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-09 | 2021-09-13 | 22,725 | $28.97 | $658.3K | 3,569,156 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 940 | $29.10 | $27.4K | 3,591,881 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 11,152 | $28.61 | $319.1K | 3,592,821 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 30,474 | $29.18 | $889.2K | 3,635,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-09-07 | 2021-09-08 | 31,340 | — | $0 | 3,603,793 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 119 | $29.99 | $3.6K | 3,665,787 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 19,057 | $30.51 | $581.4K | 3,666,153 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 247 | $31.01 | $7.7K | 3,655,906 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 1,842 | $32.84 | $60.5K | 3,701,657 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 777 | $33.84 | $26.3K | 3,700,880 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 3,164 | $32.07 | $101.5K | 3,703,499 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-04-07 | 2021-04-09 | 15,670 | — | $0 | 3,685,210 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 743,076 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 275,932 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 26,176 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 70,492 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 13,980,992 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 1,326,313 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 245,279 | — | $0 | 245,279 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 91,081 | — | $0 | 91,081 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 4,614,943 | — | $0 | 4,614,943 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 255,094 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 3,824,591 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 131,645 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,415,530 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 128,384 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 47,674 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 29,440 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 79,281 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 1,491,666 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 81,295 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 157,529 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,361,805 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 724,702 | — | $0 | 1,993,932 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 1,269,230 | — | $0 | 1,269,230 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 84,655 | — | $0 | 84,655 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 43,687 | — | $0 | 43,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 801,619 | — | $0 | 801,619 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 42,605 | — | $0 | 42,605 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 15,820 | — | $0 | 15,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 48,336 | — | $0 | 132,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,944 | — | $0 | 68,381 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 457,706 | — | $0 | 1,259,325 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,326 | — | $0 | 66,931 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 9,033 | — | $0 | 24,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 89,955 | $19.00 | $1.71M | 2,083,887 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 5,994 | $19.00 | $113.9K | 138,985 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,096 | $19.00 | $58.8K | 71,727 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 56,814 | $19.00 | $1.08M | 1,316,139 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,020 | $19.00 | $57.4K | 69,951 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 1,121 | $19.00 | $21.3K | 25,974 | SEC↗ |